HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$33.99
Day range
$33.59 - $36.09
Year range
$6.76 - $130.00
Market cap
261.47M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.43M | -2.14% |
Operating expense | 17.54M | -20.89% |
Net income | -16.83M | -12.65% |
Net profit margin | -692.84 | -15.11% |
Earnings per share | -2.64 | 99.54% |
EBITDA | -15.56M | 23.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.72M | 1,768.58% |
Total assets | 192.87M | 42.50% |
Total liabilities | 12.47M | -54.14% |
Total equity | 180.40M | — |
Shares outstanding | 7.32M | — |
Price to book | 1.30 | — |
Return on assets | -22.56% | — |
Return on capital | -24.42% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -16.83M | -12.65% |
Cash from operations | -16.58M | 5.67% |
Cash from investing | -6.00K | 94.44% |
Cash from financing | 49.53M | 23,464.62% |
Net change in cash | 32.94M | 284.03% |
Free cash flow | -9.51M | -1.75% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
81
